Haemonine (Human Coagulation Factor Ix)

Haemonine is indicated for the management of patients with inherited or acquired deficiencies of coagulation factor IX.

• Replacement therapy for hemophilia B (factor IX deficiency).
• Perioperative management to prevent bleeding during surgery in patients with factor IX deficiency.
• Treatment of acute bleeding episodes in individuals with hemophilia B.
• Prophylactic administration to reduce the frequency of spontaneous joint and muscle bleeds.

The safety profile of Haemonine reflects the typical observations for plasma‑derived coagulation factor concentrates.

Common

• Injection site erythema or pain.
• Mild headache.
• Transient fever.
• Nausea or vomiting.

Serious

• Development of inhibitors (antibodies) against factor IX.
• Allergic reactions including rash, pruritus, or anaphylaxis.
• Thrombotic events such as deep‑vein thrombosis.
• Transmission of infectious agents (very rare).

Clinicians should consider several precautions when prescribing Haemonine to ensure safe and effective use.

• Assess baseline factor IX activity and inhibitor status before initiating therapy.
• Monitor for signs of allergic reactions during and after infusion.
• Use caution in patients with a history of thrombosis or cardiovascular disease.
• Adjust dose in patients with renal or hepatic impairment as needed.
• Avoid concurrent use of other pro‑coagulant agents unless clinically justified.
• Educate patients on recognizing symptoms of inhibitor development.

Haemonine may interact with other medications that affect hemostasis or immune response.

Avoid

• Concomitant use of other factor concentrates or bypassing agents without specialist guidance.
• High‑dose pro‑coagulant drugs (e.g., activated prothrombin complex concentrates) that increase thrombotic risk.

Use with caution

• Antifibrinolytic agents such as tranexamic acid, which may enhance clot stability.
• Immunosuppressive therapies that could alter inhibitor formation.
• Vaccines administered shortly before or after infusion, which may affect immune response.